001-37468 | 26-0359894 |
(Commission File Number) | (IRS Employer Identification Number) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit Number | Description | |
99.1 | Press release issued on February 27, 2017. |
AppFolio, Inc. | |||
By: /s/ Ida Kane | |||
Name: Ida Kane | |||
Title: Chief Financial Officer |
Exhibit Number | Description | |
99.1 | Press release issued on February 27, 2017. |
• | Full year revenue is expected to be in the range of $136 million to $138 million. |
• | Weighted average common shares outstanding are expected to be approximately 33.8 million for the full year. |
December 31, | |||||||
2016 | 2015 | ||||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 10,699 | $ | 12,063 | |||
Investment securities—current | 15,473 | 10,235 | |||||
Accounts receivable, net | 2,511 | 2,048 | |||||
Prepaid expenses and other current assets | 3,537 | 3,160 | |||||
Total current assets | 32,220 | 27,506 | |||||
Investment securities—noncurrent | 26,688 | 34,417 | |||||
Property and equipment, net | 7,077 | 6,107 | |||||
Capitalized software, net | 15,539 | 10,022 | |||||
Goodwill | 6,737 | 6,737 | |||||
Intangible assets, net | 3,105 | 4,516 | |||||
Other assets | 1,217 | 1,176 | |||||
Total assets | $ | 92,583 | $ | 90,481 | |||
Liabilities and Stockholders’ Equity | |||||||
Current liabilities | |||||||
Accounts payable | $ | 937 | $ | 2,369 | |||
Accrued employee expenses | 7,550 | 5,159 | |||||
Accrued expenses | 4,044 | 3,340 | |||||
Deferred revenue | 7,638 | 4,953 | |||||
Other current liabilities | 1,192 | 1,084 | |||||
Total current liabilities | 21,361 | 16,905 | |||||
Other liabilities | 1,540 | 879 | |||||
Total liabilities | 22,901 | 17,784 | |||||
Stockholders’ equity: | |||||||
Preferred stock, $0.0001 par value, 25,000 authorized and no shares issued and outstanding as of December 31, 2016 and 2015 | — | — | |||||
Class A common stock, $0.0001 par value, 250,000 shares authorized as of December 31, 2016 and 2015; 11,691 and 9,005 shares issued and outstanding as of December 31, 2016 and 2015, respectively | 1 | 1 | |||||
Class B common stock, $0.0001 par value, 50,000 shares authorized as of December 31, 2016 and 2015; 22,028 and 24,541 shares issued and outstanding as of December 31, 2016 and 2015, respectively | 3 | 3 | |||||
Additional paid-in capital | 146,692 | 141,528 | |||||
Accumulated other comprehensive loss | (51 | ) | (153 | ) | |||
Accumulated deficit | (76,963 | ) | (68,682 | ) | |||
Total stockholders’ equity | 69,682 | 72,697 | |||||
Total liabilities and stockholders’ equity | $ | 92,583 | $ | 90,481 |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
Revenue | $ | 28,010 | $ | 20,399 | $ | 105,586 | $ | 74,977 | |||||||
Costs and operating expenses: | |||||||||||||||
Cost of revenue (exclusive of depreciation and amortization) | 11,243 | 9,465 | 44,630 | 33,903 | |||||||||||
Sales and marketing | 6,730 | 7,100 | 28,827 | 26,076 | |||||||||||
Research and product development | 3,107 | 2,594 | 12,638 | 9,554 | |||||||||||
General and administrative | 5,399 | 3,356 | 17,979 | 14,343 | |||||||||||
Depreciation and amortization | 2,823 | 1,852 | 9,935 | 6,104 | |||||||||||
Total costs and operating expenses | 29,302 | 24,367 | 114,009 | 89,980 | |||||||||||
Loss from operations | (1,292 | ) | (3,968 | ) | (8,423 | ) | (15,003 | ) | |||||||
Other income (expense), net | (3 | ) | 13 | (37 | ) | 5 | |||||||||
Interest income (expense), net | 25 | 106 | 246 | (595 | ) | ||||||||||
Loss before provision for income taxes | (1,270 | ) | (3,849 | ) | (8,214 | ) | (15,593 | ) | |||||||
Provision for income taxes | 19 | 41 | 67 | 75 | |||||||||||
Net loss | $ | (1,289 | ) | $ | (3,890 | ) | $ | (8,281 | ) | $ | (15,668 | ) | |||
Net loss per share, basic and diluted | (0.04 | ) | (0.12 | ) | (0.25 | ) | (0.73 | ) | |||||||
Weighted average common shares outstanding, basic and diluted | 33,654 | 33,407 | 33,561 | 21,336 |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
Costs and operating expenses: | |||||||||||||||
Cost of revenue (exclusive of depreciation and amortization) | $ | 150 | $ | 38 | $ | 471 | $ | 124 | |||||||
Sales and marketing | 146 | 31 | 442 | 115 | |||||||||||
Research and product development | 118 | 19 | 382 | 41 | |||||||||||
General and administrative | 1,043 | 296 | 3,006 | 727 | |||||||||||
Total stock-based compensation expense | $ | 1,457 | $ | 384 | $ | 4,301 | $ | 1,007 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) | |||||||||||||||
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
Cash from operating activities | |||||||||||||||
Net loss | $ | (1,289 | ) | $ | (3,890 | ) | $ | (8,281 | ) | $ | (15,668 | ) | |||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||||||||||
Depreciation and amortization | 2,823 | 1,852 | 9,935 | 6,104 | |||||||||||
Purchased investment premium, net of amortization | 60 | (485 | ) | 245 | (865 | ) | |||||||||
Amortization of deferred financing costs | 15 | 15 | 63 | 456 | |||||||||||
Loss on disposal of property, equipment and intangibles | 8 | 60 | 41 | 67 | |||||||||||
Stock-based compensation | 1,457 | 384 | 4,301 | 1,007 | |||||||||||
Lease abandonment | — | — | 161 | — | |||||||||||
Changes in operating assets and liabilities: | — | ||||||||||||||
Accounts receivable | 196 | 190 | (463 | ) | (746 | ) | |||||||||
Prepaid expenses and other current assets | 427 | (548 | ) | (377 | ) | (1,893 | ) | ||||||||
Other assets | 60 | 64 | (103 | ) | (56 | ) | |||||||||
Accounts payable | 205 | (606 | ) | (904 | ) | (439 | ) | ||||||||
Accrued employee expenses | 2,367 | (1,223 | ) | 2,223 | 1,887 | ||||||||||
Accrued expenses | (206 | ) | (99 | ) | 1,148 | 1,135 | |||||||||
Deferred revenue | 1,011 | 511 | 2,685 | 1,173 | |||||||||||
Other liabilities | (357 | ) | 705 | 826 | 994 | ||||||||||
Net cash provided by (used in) operating activities | 6,777 | (3,070 | ) | 11,500 | (6,844 | ) | |||||||||
Cash from investing activities | |||||||||||||||
Purchases of property and equipment | (682 | ) | (1,460 | ) | (4,242 | ) | (3,694 | ) | |||||||
Additions to capitalized software | (2,612 | ) | (2,304 | ) | (11,166 | ) | (7,677 | ) | |||||||
Purchases of investment securities | (7,217 | ) | (13,750 | ) | (31,551 | ) | (74,176 | ) | |||||||
Sales of investment securities | 2,543 | 4,100 | 12,559 | 4,100 | |||||||||||
Maturities of investment securities | 4,225 | 17,186 | 21,337 | 26,136 | |||||||||||
Cash paid in business acquisition, net of cash acquired | — | — | — | (4,039 | ) | ||||||||||
Purchases of intangible assets | — | (1 | ) | (2 | ) | (17 | ) | ||||||||
Net cash (used in) provided by investing activities | (3,743 | ) | 3,771 | (13,065 | ) | (59,367 | ) | ||||||||
Cash from financing activities | |||||||||||||||
Proceeds from stock option exercises | 92 | 29 | 352 | 357 | |||||||||||
Proceeds from issuance of restricted stock | — | — | — | 141 | |||||||||||
Proceeds from issuance of options | — | — | — | 208 | |||||||||||
Tax withholding for net share settlement | (26 | ) | — | (111 | ) | — | |||||||||
Principal payments under capital lease obligations | (5 | ) | (5 | ) | (29 | ) | (27 | ) | |||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | — | — | — | 79,570 | |||||||||||
Payments of initial public offering costs | — | (214 | ) | — | (4,213 | ) |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) | |||||||||||||||
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
Payment of contingent consideration | — | — | — | (2,429 | ) | ||||||||||
Proceeds from issuance of debt | 30 | 253 | 117 | 10,253 | |||||||||||
Principal payments on debt | (29 | ) | (241 | ) | (128 | ) | (10,241 | ) | |||||||
Payment of debt issuance costs | — | (218 | ) | — | (757 | ) | |||||||||
Net cash provided by (used in) financing activities | 62 | (396 | ) | 201 | 72,862 | ||||||||||
Net increase (decrease) in cash and cash equivalents | 3,096 | 305 | (1,364 | ) | 6,651 | ||||||||||
Cash and cash equivalents | |||||||||||||||
Beginning of period | 7,603 | 11,758 | 12,063 | 5,412 | |||||||||||
End of period | $ | 10,699 | $ | 12,063 | $ | 10,699 | $ | 12,063 |